Cargando…

High-Level rAAV Vector Production by rAdV-Mediated Amplification of Small Amounts of Input Vector

The successful application of recombinant adeno-associated virus (rAAV) vectors for long-term transgene expression in clinical studies requires scalable production methods with genetically stable components. Due to their simple production scheme and the high viral titers achievable, first generation...

Descripción completa

Detalles Bibliográficos
Autor principal:	Weger, Stefan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9867474/ https://www.ncbi.nlm.nih.gov/pubmed/36680104 http://dx.doi.org/10.3390/v15010064

Ejemplares similares

Performance of Cardiotropic rAAV Vectors Is Dependent on Production Method
por: Rao, Renuka, et al.
Publicado: (2022)

Molecular design for recombinant adeno-associated virus (rAAV) vector production
por: Aponte-Ubillus, Juan Jose, et al.
Publicado: (2017)

The anti-tumor effect and increased tregs infiltration mediated by rAAV-SLC vector
por: Li, Rilun, et al.
Publicado: (2013)

Proteomics Analysis of Co-Purifying Cellular Proteins Associated with rAAV Vectors
por: Dong, Biao, et al.
Publicado: (2014)

An efficient rAAV vector for protein expression in cortical parvalbumin expressing interneurons
por: Tkatch, Tatiana, et al.
Publicado: (2022)

Gene Delivery to Adipose Tissue Using Transcriptionally Targeted rAAV8 Vectors
por: Uhrig-Schmidt, Silke, et al.
Publicado: (2014)

Identification of Novel Retinal Pericyte-Targeting rAAV Vectors Through Directed Evolution
por: Patel, Dwani D., et al.
Publicado: (2022)

Long-term, efficient inhibition of microRNA function in mice using rAAV vectors
por: Xie, Jun, et al.
Publicado: (2012)

VectorMOD: Method for Bottom-Up Proteomic Characterization of rAAV Capsid Post-Translational Modifications and Vector Impurities
por: Rumachik, Neil G., et al.
Publicado: (2021)

Serotype-specific Binding Properties and Nanoparticle Characteristics Contribute to the Immunogenicity of rAAV1 Vectors
por: Ferrand, Maxime, et al.
Publicado: (2015)

Origins of truncated supplementary capsid proteins in rAAV8 vectors produced with the baculovirus system
por: Galibert, Lionel, et al.
Publicado: (2018)

Vectored Immunotherapeutics for Infectious Diseases: Can rAAVs Be The Game Changers for Fighting Transmissible Pathogens?
por: Zhan, Wei, et al.
Publicado: (2021)

Robust Long-term Transduction of Common Marmoset Neuromuscular Tissue With rAAV1 and rAAV9
por: Okada, Hironori, et al.
Publicado: (2013)

Subgenomic particles in rAAV vectors result from DNA lesion/break and non-homologous end joining of vector genomes
por: Zhang, Junping, et al.
Publicado: (2022)

Modular adeno-associated virus (rAAV) vectors used for cellular virus-directed enzyme prodrug therapy
por: Hagen, Sven, et al.
Publicado: (2014)

Immune Responses to rAAV6: The Influence of Canine Parvovirus Vaccination and Neonatal Administration of Viral Vector
por: Arnett, Andrea L. H., et al.
Publicado: (2011)

Controlled Release of rAAV Vectors from APMA-Functionalized Contact Lenses for Corneal Gene Therapy
por: Alvarez-Rivera, Fernando, et al.
Publicado: (2020)

rAAV8 and rAAV9-Mediated Long-Term Muscle Transduction with Tacrolimus (FK506) in Non-Human Primates
por: Ishii, Akiko, et al.
Publicado: (2020)

Monobac System–A Single Baculovirus for the Production of rAAV
por: Galibert, Lionel, et al.
Publicado: (2021)

Differential effects of two MRI contrast agents on the integrity and distribution of rAAV2 and rAAV5 in the rat striatum
por: Osting, Sue, et al.
Publicado: (2014)

Advanced Characterization of DNA Molecules in rAAV Vector Preparations by Single-stranded Virus Next-generation Sequencing
por: Lecomte, Emilie, et al.
Publicado: (2015)

Recombinant Adeno-Associated Viral Vectors (rAAV)-Vector Elements in Ocular Gene Therapy Clinical Trials and Transgene Expression and Bioactivity Assays
por: Buck, Thilo M., et al.
Publicado: (2020)

Novel approaches to render stable producer cell lines viable for the commercial manufacturing of rAAV-based gene therapy vectors
por: Emmerling, Verena V, et al.
Publicado: (2013)

Lack of Humoral Immune Response to the Tetracycline (Tet) Activator in Rats Injected Intracranially with Tet-off rAAV Vectors
por: Han, Ye, et al.
Publicado: (2010)

rAAV Vectors as Safe and Efficient Tools for the Stable Delivery of Genes to Primary Human Chondrosarcoma Cells In Vitro and In Situ
por: Madry, Henning, et al.
Publicado: (2012)

Evaluation of P2X7 Receptor Function in Tumor Contexts Using rAAV Vector and Nanobodies (AAVnano)
por: Demeules, Mélanie, et al.
Publicado: (2020)

Molecular Signature of Astrocytes for Gene Delivery by the Synthetic Adeno‐Associated Viral Vector rAAV9P1
por: Bauer, Amelie, et al.
Publicado: (2022)

Extracorporeal Delivery of rAAV with Metabolic Exchange and Oxygenation
por: Bieber, Scott, et al.
Publicado: (2013)

rAAV-delivered PTEN therapeutics for prostate cancer
por: Ai, Jianzhong, et al.
Publicado: (2021)

The recombinant adeno-associated virus vector (rAAV2)-mediated apolipoprotein B mRNA-specific hammerhead ribozyme: a self-complementary AAV2 vector improves the gene expression
por: Zhong, Shumei, et al.
Publicado: (2004)

Low endotoxin E. coli strain-derived plasmids reduce rAAV vector-mediated immune responses both in vitro and in vivo
por: Zheng, Qingyun, et al.
Publicado: (2021)

Neuroprotection by rAAV-mediated gene transfer of bone morphogenic protein 7
por: Heinonen, Ann-Marie, et al.
Publicado: (2014)

TGF‐β gene transfer and overexpression via rAAV vectors stimulates chondrogenic events in human bone marrow aspirates
por: Frisch, Janina, et al.
Publicado: (2016)

Mannitol-facilitated CNS entry of rAAV2 vector significantly delayed the neurological disease progression in MPS IIIB mice
por: McCarty, D M, et al.
Publicado: (2009)

Regulated hAAT Expression from a Novel rAAV Vector and Its Application in the Prevention of Type 1 Diabetes
por: Ma, Hongxia, et al.
Publicado: (2019)

Computational and molecular tools for scalable rAAV-mediated genome editing
por: Stoimenov, Ivaylo, et al.
Publicado: (2015)

Enhanced protective immunity of the chimeric vector-based vaccine rAdV-SFV-E2 against classical swine fever in pigs by a Salmonella bacterial ghost adjuvant
por: Xia, Shui-Li, et al.
Publicado: (2016)

Immunomodulation in Administration of rAAV: Preclinical and Clinical Adjuvant Pharmacotherapies
por: Chu, Wing Sum, et al.
Publicado: (2021)

Durability of transgene expression after rAAV gene therapy
por: Muhuri, Manish, et al.
Publicado: (2022)

Subcellular distribution of the rAAV genome depends on genome structure
por: Oh, Nuri, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_j8udl34qkhq9v6fbvq8d1q2rkl